PLX - Protalix plans Phase 2 for PRX-115 in H2 2025, projects higher royalty revenues by 2030
2025-03-17 10:23:20 ET
More on Protalix BioTherapeutics
- Protalix BioTherapeutics, Inc. (PLX) Q4 2024 Earnings Call Transcript
- Seeking Alpha’s Quant Rating on Protalix BioTherapeutics
- Historical earnings data for Protalix BioTherapeutics
- Financial information for Protalix BioTherapeutics